Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
Targeted therapies such as kinase inhibitors and monoclonal antibodies have dramatically altered cancer care in recent decades. Although these targeted therapies have improved patient outcomes in several cance...
Genome Medicine 2017 9:37
Published on: 21 April 2017